Compare BLCO & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | HCC |
|---|---|---|
| Founded | 1853 | 2015 |
| Country | Canada | United States |
| Employees | 13000 | N/A |
| Industry | Ophthalmic Goods | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.2B |
| IPO Year | 2022 | 2017 |
| Metric | BLCO | HCC |
|---|---|---|
| Price | $16.94 | $89.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $19.04 | ★ $109.33 |
| AVG Volume (30 Days) | 288.1K | ★ 481.2K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.03 |
| Revenue | ★ $5,101,000,000.00 | $1,310,043,000.00 |
| Revenue This Year | $7.71 | $52.20 |
| Revenue Next Year | $5.86 | $5.88 |
| P/E Ratio | ★ N/A | $29.41 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.77 | $61.87 |
| 52 Week High | $18.92 | $111.42 |
| Indicator | BLCO | HCC |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 36.60 |
| Support Level | $16.94 | $82.72 |
| Resistance Level | $17.21 | $92.19 |
| Average True Range (ATR) | 0.39 | 3.29 |
| MACD | -0.03 | -0.88 |
| Stochastic Oscillator | 45.28 | 2.48 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Warrior Met Coal Inc produces and exports met or steelmaking coal, which is used as a component for steel production by metal manufacturers in Europe, South America, and Asia. The company is involved in longwall mining operations in its underground mines based in Alabama, Mine No. 4, Mine No. 7, and Blue Creek. Additionally, its natural gas operations remove and sell natural gas from owned and leased coal seams by reducing natural gas levels in its mines. The company generates revenue mainly through the production of steelmaking coal for sale to the steel industry. Geographically, the firm generates maximum revenue from its customers in Asia, followed by Europe, South America, and the United States.